Immunohistochemical detection of p53 protein expression in mammary carcinoma: A study of 80 cases

Pathology

Volumn 27, Issue 4, 1995, Pages 365-369

  Fernando, Sujatha S E ^a   Xiaojuan, Wu ^a   McKenzie, Paul R ^a   Johnson, Stephen J ^a  

^a SYDNEY SOUTH WEST AREA HEALTH SERVICE   (Australia)

Author keywords

Mammary carcinoma; P53 protein

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN P53; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; BREAST TUMOR; CANCER INVASION; CHEMISTRY; FEASIBILITY STUDY; HUMAN; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PATHOLOGY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; FEASIBILITY STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; SENSITIVITY AND SPECIFICITY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029382689     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313029500169323     Document Type: Article

References (24)

1. Reich NC, Levine AJ et al. Growth regulation of a cellular tumor antigen, p53 in nontransformed cells. Nature 1984; 308: 199-201.
2. Lane DP. p53, guardian of the genome. Nature 1992; 358: 15-6.
3. Chen PL, Chen YM et al. Genetic mechanisms of tumour suppression by the human p53 gene. Science 1990; 250: 1576-80.
4. Hollstein M, Sidransky D et al. p53 mutations in human cancers. Science 1991; 253: 49-53.
5. Harris CC, Hollstein M. Clinical implications of the p53 tumour suppressor gene. N Engl J Med 1993.
6. Levine AJ, Momand J et al. The p53 tumour suppressor gene. Nature 1991; 531: 453-6.
7. Cattoretti G, Rilke F et al. p53 expression in breast cancer. Int J Cancer 1988; 41: 178-83.
8. Crawform LV, Pim DC et al. Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer. Int J Cancer 1982; 30: 403-8.
9. Thor AD, Moore DH et al. Accumulation of p53 tumour suppressor gene protein. J Natl Cancer Inst 1992; 84: 845-55.
10. Domagala W, Harezga B et al. Nuclear p53 protein accumulates preferentially in medullary and high-grade ductal but rarely in lobular breast carcinomas. Am J Pathol 1993; 142: 669-74.
11. Hurlimann J. Prognostic value of p53 protein expression in breast carcinomas. Path Res Pract 1993; 198: 996-1003.
12. Silvestrini R, Benini E et al. p53 as an independent prognostic marker in lymph node-negative breast cancer patients. J Natl Cancer Inst 1993; 85: 965-70.
13. Caleffi M, Teague MW et al. p53 gene mutations and steroid receptor status in breast cancer clinicopathological correlations and prognostic assessment. Cancer 1994; 73: 2147-56.
14. Barnes DM, Dublin EA et al. Immunohistochemical detection of p53 protein in mammary carcinoma: An important new independent indicator of prognosis? Human Pathol 1993; 24: 469-76.
15. World Health Organization. Histological typing of breast tumours. (1968, second edition 1981).
16. Bloom HJC, Richardson WW. Histological grading and prognosis in breast cancer. Br J Cancer 1957; 11: 359-77.
17. Elston CW. Grading of invasive carcinoma of the breast. In: Page D, Anderson T, eds. Diagnostic histopathology of the breast. Edinburgh: Churchill Livingstone, 1987; 300-11.
18. Remmele W, Stegner HE. Immunohistochemischer Nachweis von Östrogenrezeptoren (ERICA) in Mammarkarzinomgewebe: Vorschlag zur einheitlichen Formulierung des Untersuchungs-befundes. Dtsch Ärztebl 1986; 83: 3362-4.
19. Hanzal E, Gitsh G et al. Immunohistochemical detection of mutant p53-suppressor gene product in patients with breast cancer: influence on metastasis-free survival. Anticancer Res 1992; 12: 2325-30.
20. Walker RA, Dearing SJ et al. Expression of p53 protein in infiltrating and in-situ breast carcinomas. J Pathol 1991; 165: 203-11.
21. Friedrichs K, Gluba S et al. Overexpression of p53 and prognosis in breast cancer. Cancer 1993; 72: 3641-7.
22. Iwaya K, Tsuda H et al. Nuclear p53 immunoreaction associated with poor prognosis breast cancer. Jpn J Cancer Res 1991; 82: 835-40.
23. Allred DC, Clark GM et al. Association of p53 protein expression with tumour cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst 1993; 85: 200-6.
24. Ostrowski JL, Sawan A et al. p53 expression in human breast cancer related to survival and prognostic factors: an immunohistochemical study. J Pathol 1991; 164: 75-81.